In breast cancer treatment, several key molecular targets have been identified, including human epidermal growth factor receptor 2, vascular endothelial growth factor, folate receptors, somatostatin receptors, vascular endothelial cell adhesion molecules, estrogen receptors, and cyclooxygenase-2 (97). This evidence concerns the gene ERBB2 and breast carcinoma.